Acceleron Pharma
XLRN
#1581
Rank
NZ$17.66 B
Marketcap
$288.93
Share price
0.00%
Change (1 day)
14,553.11%
Change (1 year)

Market capitalization of Acceleron Pharma (XLRN)

Last known market cap: NZ$17.66 Billion

As of September 2024 Acceleron Pharma has a market cap of NZ$17.66 Billion. This makes Acceleron Pharma the world's 1581th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Acceleron Pharma from 2013 to 2022

End of year Market Cap

Year Market cap Change
2022NZ$17.21 B7.87%
2021NZ$15.96 B48.92%
2020NZ$10.71 B156.7%
2019NZ$4.17 B39.08%
2018NZ$3.00 B11.06%
2017NZ$2.70 B94.38%
2016NZ$1.39 B-41.47%
2015NZ$2.37 B47.51%
2014NZ$1.61 B17.84%
2013NZ$1.36 B

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
NZ$291.78 B 1,551.32%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$204.94 B 1,059.86%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$641.31 B 3,529.49%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$33.78 M-99.81%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.30 B-98.29%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.15 B-99.12%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$271.67 B 1,437.51%๐Ÿ‡บ๐Ÿ‡ธ USA